Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 September 2024

The composition of the UFS Council is stipulated in the UFS Statute, which was published in the Government Gazette on 10 March 2023. The Convocation has to elect two (2) external Convocation members (who are neither employees nor students of the UFS) to the Council, as required by the Statute of the UFS. The elected members will serve on the Council for a period of four years.

The Convocation comprises all persons who obtained a formal qualification from the UFS, as well as all permanent and retired academic staff members.

Members of the Convocation are invited to submit written nominations by using the Nomination Form attached hereto.

Every nomination form must be signed by 2 (two) members of the Convocation and must contain the written acceptance of the nomination by the nominee under his/her signature, as well as an abridged CV and a motivation of ± 200 words.

All nominations must reach the office of the Registrar no later than 4 October  2024.

If more than two persons are nominated, an election will be held as stipulated in the Interim Institutional Rules. More information regarding this process will follow at that stage. 

Nominations are to be submitted to:
     e-mail: registrar@ufs.ac.za

or hand-delivered to:
     Mr NN Ntsababa
     Room 51 
     1st Floor
     Main Building
     UFS Bloemfontein Campus

For any enquiries, please contact Mr NN Ntsababa at registrar@ufs.ac.za or +27 51 401 3796.

Kindly take note that late or incomplete nominations will not be accepted or considered.

Each nomination must be submitted separately.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept